DBV Technologies S.A. — Chart, Price & News (NASDAQ:DBVT)

Open full chart

Financials

Overview Finanzbericht Statistics Dividends

Quarterly Annual

Market Capitalization 2.87 B
Employee 117
Founded 2002
CEO N/A
Website www.dbv-technologies.com
Headquarter France
FIGI BBG0076D3T39
Industry Technology

Total revenue

Net income

Basic earnings per share (Basic EPS)

Total debt

Free cash flow

Cash & equivalents

2.87 B Market capitalization

Price to earnings ratio

-2.64

Price to sales ratio

72.2

Dividends per share

—

Dividend yield %

—

DBV Technologies S.A. - American Depositary Shares

DBV Technologies SA is a publicly owned French biopharmaceutical firm headquartered in Bagneux, France. DBV Technologies is known for developing "Viaskin" technology for administering allergens or antigens to intact skin while avoiding any transfer to the blood. Viaskin Peanut clinical development has received Fast Track designation from the US Food and Drug Administration.